Takashi Mitsui

Social Insurance Saitama Chuo Hospital

Papers

1

Total Citations

6

H-Index

1

About

Dr. Takashi Mitsui is a pioneering surgeon-scientist whose work centers on advancing minimally invasive surgical techniques for esophageal cancer, with a particular focus on esophageal squamous cell carcinoma. His major contribution lies in the development and clinical validation of robot-assisted transmediastinal esophagectomy (RATME), a novel approach designed to reduce the significant invasiveness associated with traditional open transthoracic esophagectomy (oTTE). By demonstrating the feasibility and safety of RATME, Dr. Mitsui has addressed a critical gap in surgical oncology, offering patients a potentially less traumatic alternative without compromising oncologic outcomes. His most cited work, a 2025 study on survival outcomes following RATME, has already garnered 6 citations, underscoring its immediate impact and the high interest in his technique among peers. This research is particularly notable for tackling the long-term survival data that were previously unclear, providing essential evidence for the broader adoption of robotic-assisted approaches. Dr. Mitsui’s contributions are helping to shape the future of esophageal cancer surgery, bridging the gap between technological innovation and tangible patient benefit.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Survival outcomes of robot-assisted transmediastinal esophagectomy in patients with esophageal squamous cell carcinoma
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Social Insurance Saitama Chuo Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago